nicolejuffermans

1/20. Democracy is precious and exceptional.

General Assembly on air now! All @ESICM members are more than welcome in room 127-128 at #LIVES2024 @ElieAzoulay5 @criticcaredoc @DrMCecconi @ESICM_CEO @katerinailiopou @Dr_Cit @njuffermans @LauretaPereta @imloeches @Lennie333 #GiacomoGrasselli #MariaTheodorakopoulou

@PulmCrit @drshahrul80 RCT suggesting IV iron is superior then PO iron in stimulating erythropoiesis in patients recovering from gut surgery. Which is compatible with the fact that inflammation suppresses iron uptake from the gut thelancet.com/journals/lanha…

updating the chapter on anemia in hospitalized/ICU pts any useful pearls or great references on the approach to anemia? also, would be super interested to hear about how people are using IV iron for iron deficiency (start with trying PO iron versus going straight to IV)?

@PulmCrit @drshahrul80 Important cause of anemia in ICU is inflammation; anti-inflammatory agents inhibit its onset. Which is not to say to give steroids for this purpose. pubmed.ncbi.nlm.nih.gov/38594746/

@PulmCrit Important cause of anemia in ICU is inflammation. Which is not to say to give steroids in ICU patients to reduce onset of anemia. pubmed.ncbi.nlm.nih.gov/38594746/

🚑ReFit algorithm - closed-loop system for real-time treatment of hemorrhagic shock. Stabilized 🐷 both on ground and in air. ✅ Better care in remote/moving settings, ensuring stability until reaching advanced care. Read more: t.ly/6QMNP #FOAMed #innovations

Read my view on #rotem testing in #trauma at @yourICM here rdcu.be/dGDlz

⚙️During ECMO there may be thrombus formation, hemolysis and impaired gas exchange. 🩸Carboxyhemoglobin (COHb) is generated upon red cell lysis. 📰Cohort study to evaluate COHb in the ABG as a novel marker of oxygenator dysfunction! ▶️t.ly/TbcW_

@fasc1nate 5

How many numbers can you see?

@fasc1nate 10

How many faces do you see in this picture?

@TeamCaptainJohn @yourICM @Dr_Cit @karimbrohi @FOAMecmo @JulieHelmsICU @bhwords @theTHORnetwork @ATACCFaculty @traumadoctors I totally agree with this. There are different plasma products out there that may impact outcome differently. Up to is to use nomenclature correctly Ls

@yourICM @Dr_Cit @karimbrohi @FOAMecmo @JulieHelmsICU @bhwords @njuffermans @theTHORnetwork @ATACCFaculty @traumadoctors Looking forward to reading it. Super annoying, I know. But can we stop using “FFP” as a colloquialism for “plasma”…few trauma patients are getting actual FFP. Using correct nomenclature is important.

4‑factor prothrombin complex concentrate in bleeding #trauma patients 🩸 PCC to treat post‑traumatic coagulopathy 🩸 recent evidence for PCC after trauma 🩸 what has the PROCOAG trial added to our understanding of coagulopathy? #FOAMcc on @yourICM 🔓 rdcu.be/dhETh

@fasc1nate Cold War

In your opinion, what movie is an absolute 100/100?

🗣️📣 We are are delighted to share we achieved an 𝐈𝐦𝐩𝐚𝐜𝐭 𝐅𝐚𝐜𝐭𝐨𝐫 𝐨𝐟 𝟑.𝟓 the year 2022 ‼️ @ESICM official journal dedicated to translational research. We especially thank the talented authors, our committed reviewers, our publisher and of course @njuffermans

Rest in peace , dear Paolo. Thank you for your contributions to improve as ICU doctors.

In todays JAMA, an anzic trial did not show benefit of SDD on mortality. But no cultures were taken to ensure decontamination. And ‘adherence to protocol’ was scored a yes after a single gift…Ask any Dutch intensivist: this is not SDD jamanetwork.com/journals/jama/…

The 5th International Symposium on Acute Pulmonary Injury Translational Research is back! #INSPIRES 🗓️November 17 & 18, 2022 🗺️Hospital Universitario de Getafe, Madrid, Spain Endorsed by @semicyuc, @SaludISCIII & @ESICM With the support of #ICMx @njuffermans @johnglaffey

The pain of loosing a wonderful, committed and dazzling colleague. We are all shocked. Condolences to the family and the teams. RIP Sophie

@marcmtk @yourICM @Dr_Cit @ABsteward @FOAMecmo @iceman_ex @avkwong @ArmandGirbes @MarcLeone8 @Manu_Malbrain @ElieAzoulay5 I don’t think you are very far from their interpretation? The trial failed to show non inferiority. This means that there may be a difference, which is what the authors also acknowledge.

📢 Ground-breaking release(s) at #LIVES40 with @ESICM President @DrMCecconi, @ICMexperimental Editor-in-Chief @njuffermans & @yourICM Editor-in-Chief @Dr_Cit 🧵 Follow the thread to read (full open access) 2 just published studies! #FOAMcc

🧫 8 vs 15 days ABT for Pseudomonas aeruginosa VAP in adults, iDIAPASON RCT: no differences in composite or separate outcomes (90-day mortality/VAP recurrence) between short & long duration treatment. 📢 @yourICM ground-breaking release #LIVES40 #FOAMcc 🖇 bit.ly/3wa6Fhj